Filing Details
- Accession Number:
- 0001104659-20-010938
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-05 06:03:13
- Reporting Period:
- 2020-01-31
- Accepted Time:
- 2020-02-05 06:03:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1477845 | Annovis Bio Inc. | ANVS | Pharmaceutical Preparations (2834) | 262540421 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1563273 | Brian Jeffrey Mcgroarty | C/O Annovis Bio, Inc. 1055 Westlakes Drive, Suite 300 Berwyn PA 19312 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-31 | 33,333 | $6.00 | 33,333 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-02-03 | 19,336 | $7.15 | 52,669 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-02-03 | 164 | $7.17 | 52,833 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The reporting person acquired these shares in the initial public offering of Annovis Bio, Inc.
Billionaire Hedge Funds
